You are here: Industry Insights > revenue

News List

Cell line development services market to value $2.4 billion by 2030 europeanpharmaceuticalreview
August 11, 2021
New report suggests the cell line development services market will witness a 14.3 percent CAGR between 2021 and 2030.
AstraZeneca India’s Q1 net profit declines 45 per cent expresspharma
August 11, 2021
Revenue from operations stood at Rs 175.40 crores for the quarter under consideration. It was Rs 193.57 crores for the same period a year ago.
Moderna records $4.4bn total revenue in Q2 2021 pharmaceutical-technology
August 09, 2021
Moderna has reported total revenue of $4.4bn in the second quarter (Q2) of the fiscal year (FY) 2021, a surge from $67m in the same quarter last year.
Lincoln Pharmaceuticals reports 28.33 per cent rise in standalone net profit in Q4 FY21 expresspharma
May 26, 2021
Lincoln Pharmaceuticals has reported net profit of Rs 11.85 crores in Q4FY21 as against the net profit of Rs 9.23 crores in the corresponding period last year, growth of 28.33 per cent.
China Pharma Holdings, Inc. Reports 33% YoY Increase in First Quarter 2021 Revenue prnasia
May 17, 2021
China Pharma Holdings, Inc., a specialty pharmaceutical company, announced financial results for the quarter ended March 31, 2021.
Takeda Pharmaceutical reports decline in FY2020 revenue pharmaceutical-technology
May 13, 2021
Takeda Pharmaceutical has reported a 2.8% year-on-year (YOY) decrease in its reported revenue to JPY3,197.8bn ($29.4bn) during the fiscal year 2020 (FY2020) ended 31 March 2021.
Seegene reports solid results in the first quarter of 2021 with KRW 351.8 billion prnasia
May 12, 2021
Seegene Inc., a molecular diagnostics company reported its financial results for the first quarter of 2021, with reports showing robust earnings.
AstraZeneca Announces First Quarter 2021 Results americanpharmaceuticalreview
May 06, 2021
AstraZeneca delivered robust revenue growth of 15% (11% at CER) in the quarter to $7,320m; excluding the contribution from the pandemic COVID-19 vaccine, revenue growth increased by 11% (7% at CER) to $7,045m.
GSK reports decline in Q1 2021 revenue due to Covid-19 disruption pharmaceutical-technology
April 30, 2021
GlaxoSmithKline (GSK) has reported an 18% year-on-year (YOY) decline in revenue in the first quarter of this year to £7.41bn and down 15% at constant currency due to disruption caused by the global Covid-19 pandemic.
Eli Lilly reports increase in first-quarter worldwide revenue pharmaceutical-technology
April 29, 2021
Eli Lilly and Company has reported worldwide revenue of $6.806bn for the first quarter of this year, a 16% rise compared with the same quarter of last year.

Previous page 1 2 3 4 5 Next page